hERG: The long and short of it

Heart Rhythm

Volumn 5, Issue 4, 2008, Pages 591-592

  Duff, Henry J ^a  

^a LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; DOFETILIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; NIFLUMIC ACID; NS 1643; NS 3623; PD 118057; POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KV11.1; QUINIDINE; RPR 260243; SODIUM CHANNEL; UNCLASSIFIED DRUG;

ARRHYTHMOGENESIS; CONFORMATIONAL TRANSITION; EDITORIAL; ELECTROCARDIOGRAM; EPICARDIUM; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART PACING; HEART PROARRHYTHMIA; HYPERPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; REFRACTORY PERIOD; SHORT QT SYNDROME;

ACTION POTENTIALS; ANTHRANILIC ACIDS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; POTASSIUM CHANNELS, VOLTAGE-GATED; QUINIDINE;

EID: 40849114442     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.02.041     Document Type: Editorial

References (10)

1. Smith P.L., Baukrowitz T., and Yellen G. The inward rectification mechanism of the HERG cardiac potassium channel. Nature 379 (1996) 833-836
2. Kang J., Chen X.L., Wang H., et al. Discovery of a Small Molecule Activator of the Human Ether-a- Go-Go-Related Gene (HERG) Cardiac K+ Channel. Mol Pharmacol 67 (2005) 827-836
3. Casis O., Olesen S.P., and Sanguinetti M.C. Mechanism of Action of a Novel Human Ether-a-Go-Go-Related Gene Channel Activator. Mol Pharmacol 69 (2006) 658-665
4. Hansen R.S., Diness T.G., Christ T., Demnitz J., et al. Activation of Human Ether-a-Go-Go-Related Gene Potassium Channels by the Diphenylurea 1,3-Bis-(2-Hydroxy-5-Trifluoromethyl-Phenyl)-Urea (NS1643). Mol Pharmacol 69 (2006) 266-277
5. Hansen R.S., Diness T.G., Christ T., et al. Biophysical Characterization of the New Human Ether-a-Go-Go-Related Gene Channel Opener NS3623 [N-(4-Bromo-2-(1H-Tetrazol-5-Yl)-Phenyl)-N'-(3'-Trifluoromethylphenyl)Urea]. Mol Pharmacol 70 (2006) 1319-1329
6. Zhou J., Augelli-Szafran C.E., Bradley J.A., et al. Novel Potent Human Ether-a-Go-Go-Related Gene (HERG) Potassium Channel Enhancers and Their in Vitro Antiarrhythmic Activity. Mol Pharmacol 68 (2005) 876-884
7. Zeng H., Lozinskaya I.M., Lin Z., et al. Mallotoxin Is a Novel Human Ether-a-Go-Go-Related Gene (HERG) Potassium Channel Activator. J Pharmacol Exp Ther 319 (2006) 957-962
8. Wolpert C., Schimpf R., Giustetto C., et al. Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol 1 (2005) 54-58
9. Patel C, Antzelevitch C. Cellular Basis for Arrhythmogenesis in an Experimental Model of the SQT1 Form of the Short QT Syndrome. Heart Rhythm. In Press.
10. Seebohm G. Activators of Cation Channels: Potential in Treatment of Channelopathies. Mol Pharmacol 67 (2005) 585-588